RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
  Dementia
   Alzheimer's
  Parkinson's
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Dementia Channel

subscribe to Dementia newsletter
Latest Research : Aging : Dementia

   EMAIL   |   PRINT
Mental faculties in Dementia not improved by homocysteine-lowering supplements

Jun 29, 2006 - 4:50:00 AM , Reviewed by: Venkat Yelamanchili
"This incredible support from local people was vital in making this a high-powered trial that met the demanding standards of the New England Journal of Medicine.. Researchers from around the world continue to be amazed at the unique levels of participation Otago nutrition studies enjoy."

 
[RxPG] Giving healthy older people supplements to reduce high blood levels of an amino acid linked to dementia does not help their cognitive performance, according to a major University of Otago clinical study published today in one of world's top medical journals.

In a two-year clinical trial involving more than 250 healthy older people, a multidisciplinary Otago research team investigated whether lowering their high blood levels of the amino acid, homocysteine, would positively influence their cognitive function, says study co-author Dr Jennifer McMahon, who conducted the trial as part of her PhD in Human Nutrition.

Previous international studies have shown an inverse relationship between homocysteine levels and cognitive function in older people, leading to hopes that lowering homocysteine might be the key to combating cognitive decline, says Associate Professor Murray Skeaff, another co-author.

"A high blood concentration of homocysteine is known as a significant risk factor for developing Alzheimer's, and is also linked to other forms of dementia and cardiovascular disease," says Assoc Prof Skeaff.

Over a two-year period, the Otago team of Human Nutrition, Psychology and Preventive & Social Medicine researchers tested whether lowering elevated levels of homocysteine in healthy over-65 year-olds through supplements would improve their performance in memory, thinking, language and learning tests.

The 253 trial participants (none of whom had been diagnosed with dementia but all of whom had high homocysteine levels) were divided into two groups. One group received a daily pill containing folate and vitamins B6 and B12, and the other group a placebo.

The researchers administered a battery of cognitive tests at the outset, one year in, and at the end of the two-year trial. While homocysteine levels fell sharply in the supplement group, the researchers found no significant overall difference between the groups' respective combined performances on a variety of cognitive tests, says Dr McMahon.

"Our study adds to the growing evidence pointing towards homocysteine as being merely a marker or a consequence of a number of health problems, rather than - as had previously been hoped - a key risk factor that could be tackled to prevent or treat them."

Doctors who are currently advising older patients to take supplements as a preventive measure against cognitive decline might need to reconsider that advice, she says.

The researchers wished to thank the Dunedin Community for the strong response when they called for volunteers to participate in the study.

Assoc Prof Skeaff added: "This incredible support from local people was vital in making this a high-powered trial that met the demanding standards of the New England Journal of Medicine.. Researchers from around the world continue to be amazed at the unique levels of participation Otago nutrition studies enjoy."



Publication: Findings from the study which is the first long-term research of its kind appear in this week's issue of the prestigious New England Journal of Medicine.
On the web: www.otago.ac.nz 

Advertise in this space for $10 per month. Contact us today.


Related Dementia News


Subscribe to Dementia Newsletter

Enter your email address:


 Additional information about the news article
The clinical trial was conducted by Dr McMahon as part of her doctoral studies and was co-authored by Assoc Prof Skeaff, Dr Tim Green and Professor Jim Mann of Human Nutrition, Professor Bob Knight of Psychology and Dr Sheila Williams of Preventive & Social Medicine.

About Dr Jennifer McMahon

Dr Jennifer McMahon spent 16 years as a nutritionist with the International Committee of the Red Cross, working in war zones and areas of extreme poverty in Africa and South-East Asia, before returning to Dunedin. She earned an MBE and one of the Red Cross' highest honours, the Florence Nightingale medal, for her work. Dr McMahon has also completed Master of Consumer and Applied Science, and Master of Business Administration degrees at the University of Otago.
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)